Telomium is a biotechnology company pioneering a novel cancer immunotherapy that utilizes a unique ribonucleoprotein composition. This innovative treatment mimics a viral attack, triggering an autoimmune response specifically targeting cancer cells while minimizing side effects, offering new hope for cancer patients.